Topic

Pharmaceutical strategy

A collection of 1 issue

Bristol Myers Squibb Secures Patent Protection Amid Upcoming Expiry

Bristol Myers Squibb gains approval to safeguard sales as the intravenous patent nears expiry, highlighting strategic pharmaceutical planning and revenue impact.